BioTech Mag Search: Genes
Identification of Metabolic Syndrome-Related miRNA-mRNA Regulatory Networks and Key Genes Based on Bioinformatics Analysis
12 days ago - By Springer
Abstract
Metabolic syndrome, which affects approximately one-quarter of the world's population, is a combination of multiple traits and is associated with high all-cause mortality, increased cancer risk, and other hazards. It has been shown that the epigenetic functions of miRNAs are closely related to metabolic syndrome, but epigenetic studies have not yet fully elucidated the regulatory network and key genes associated with metabolic syndrome. To perform data analysis and screening of potential differentially expressed target miRNAs, mRNAs and genes based on a bioinformatics approach...
Read more ...
Search by Tags
Genes Cancer Bioinformatics Gene Bioinformatic
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
Copying nature to help plants resist viruses
For thousands of years, crops have been shaped by domestication processes. Farmers cross-breed and select new varieties, adapted to constantly changing environments. Although...
A New Phase
The evolution of clinical trials is accelerating, driven by emerging technologies, social imperatives and the next public health crisis.
Biological Dynamics, Perlmutter Cancer Center at NYU Langone Health...
SAN DIEGO & NEW YORK--Biological Dynamics, a company commercializing its exosome-isolation ExoVerita™ platform, announced a collaboration with the Perlmutter Cancer Center at...
Arima Genomics Announces Agreement with Protean BioDiagnostics to Make Arima...
SAN DIEGO--Arima Genomics announces an agreement with Protean BioDiagnostics to make their gene fusion test widely available to clinicians.
Artificial Intelligence Aids Discovery of Super Tight-Binding Antibodies
UC San Diego scientists developed an artificial intelligence tool that could accelerate the development of new high affinity antibody drugs.
Artiva Biotherapeutics Receives FDA Fast Track Designation for AB-101
SAN DIEGO-- biotech-Artiva Biotherapeutics Receives FDA Fast Track Designation for AB-101
Biosero and Virscidian Announce Collaboration for Medicinal Chemistry...
SAN DIEGO & CARY, N.C.--Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and Virscidian, developer of solutions to automate...
Poseida Therapeutics Announces Board Change
Eric Ostertag, M.D., Ph.D., Founder and current Executive Chairman, to retire from the Board of Directors and remain a consultant to the Company SAN DIEGO, Jan. 31, 2023...
Eclipsebio Launches eRibo™ for Improved Methods to Profile Protein...
SAN DIEGO-- RNA-Eclipsebio Launches eRibo™ for Improved Methods to Profile Protein Translation; Technology Details Will Be Presented at Keystone Symposia
HiFi long-read sequencing brings more accuracy to population genomics studies
Population genomics initiatives are gaining traction around the world. There are currently more than 20 active programs spread around the globe, and these programs aim to...